BioMarin Pharmaceutical Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €3.45B +3.5% €1.21B +9.9% 35.0% +0.021 pp €1.19B +7.5% 34.5% +0.013 pp
    (estimated) €3.34B +5.5% €1.10B +22.0% 33.0% +0.045 pp €1.11B +10.4% 33.2% +0.015 pp
    (estimated) €3.17B +7.3% €902.21M +19.7% 28.5% +0.030 pp €1.00B +12.2% 31.7% +0.014 pp
    (estimated) €2.95B +8.9% €753.49M +15.4% 25.5% +0.014 pp €895.68M +77.7% 30.4% +0.12 pp
    (estimated) €2.71B +11.2% €652.67M +79.3% 24.1% +0.091 pp €504.09M -11.8% 18.6% -0.049 pp
    €2.43B +18.0% €364.09M +154.6% 15.0% +0.080 pp €571.70M +151.2% 23.5% +0.12 pp
    €2.06B +15.4% €142.99M +18.4% 6.9% +0.0018 pp €227.63M -13.2% 11.0% -0.036 pp
    €1.79B +13.5% €120.74M -320.9% 6.8% +0.10 pp €262.23M -27.4% 14.7% -0.083 pp
    €1.57B -0.8% -€54.66M -107.5% -3.5% -0.49 pp €361.45M +90.1% 23.0% +0.11 pp
    €1.59B +9.2% €728.45M -3,681.1% 45.9% +0.47 pp €190.11M +5.3% 12.0% -0.0044 pp
    €1.45B +14.3% -€20.34M -69.1% -1.4% +0.038 pp €180.54M +28.4% 12.4% +0.014 pp
    €1.27B +13.5% -€65.86M -34.0% -5.2% +0.037 pp €140.59M -13.5% 11.1% -0.034 pp
    €1.12B +17.6% -€99.83M -81.4% -8.9% +0.48 pp €162.45M -339.7% 14.5% +0.22 pp
    €952.62M +25.5% -€537.54M +266.8% -56.4% -0.37 pp -€67.77M -1,432.3% -7.1% -0.078 pp
    €759.04M +18.5% -€146.54M +28.2% -19.3% -0.015 pp €5.09M -86.8% 0.7% -0.054 pp
    €640.60M +36.9% -€114.27M -24.0% -17.8% +0.14 pp €38.63M +725.0% 6.0% +0.050 pp
    €467.83M +9.5% -€150.42M +54.2% -32.2% -0.093 pp €4.68M -91.2% 1.0% -0.11 pp
    €427.09M +13.5% -€97.53M +112.4% -22.8% -0.11 pp €53.04M -64.1% 12.4% -0.27 pp
    €376.46M +17.3% -€45.92M -126.2% -12.2% -0.67 pp €147.54M +153.6% 39.2% +0.21 pp
    €320.94M +15.9% €175.55M -42,276.0% 54.7% +0.55 pp €58.18M -61.6% 18.1% -0.37 pp
    €276.92M +9.5% -€416.24K -101.6% -0.2% -0.11 pp €151.43M +276.2% 54.7% +0.39 pp
    €252.89M +143.9% €26.30M -295.1% 10.4% +0.23 pp €40.25M -490.6% 15.9% +0.26 pp
    €103.70M +44.4% -€13.48M -44.6% -13.0% +0.21 pp -€10.31M -52.6% -9.9% +0.20 pp
    €71.83M +228.1% -€24.34M -61.6% -33.9% +2.6 pp -€21.76M -57.3% -30.3% +2.0 pp
    €21.89M +37.7% -€63.35M -60.4% -289.3% +7.2 pp -€50.94M +45.4% -232.7% -0.12 pp
    €15.90M +54.1% -€159.88M +147.3% -1,005.5% -3.8 pp -€35.03M -40.3% -220.3% +3.5 pp
    €10.32M -13.1% -€64.65M -2.1% -626.4% -0.70 pp -€58.70M +41.2% -568.8% -2.2 pp
    €11.87M +19.0% -€66.07M +14.6% -556.5% +0.21 pp -€41.57M +827.7% -350.1% -3.1 pp
    €9.98M -5.1% -€57.66M +80.9% -577.9% -2.7 pp -€4.48M -42.5% -44.9% +0.29 pp
    €10.51M +76.7% -€31.87M +33.1% -303.1% +0.99 pp -€7.79M -191.3% -74.1% -2.2 pp
    €5.95M +481.3% -€23.94M +128.2% -402.4% +6.2 pp €8.53M -688.5% 143.4% +2.9 pp
    €1.02M -€10.49M -1,025.0% -€1.45M -141.7%

    Notifications